Fosamax Side Effects Lawsuits Rise as New FDA Warnings Are Expected
In response to the growing number of Fosamax side effects lawsuits, the Food and Drug Administration is expected to issue new warnings for the drug.
Lawsuits have already been filed in several states against Merck, the manufacturer of Fosamax, alleging that the drug caused osteoporosis of the jaw in some female patients. Researchers at the University of Colorado have suggested that long-term use of Fosamax and similar bone-density drugs such as Actonel and Boniva can significantly weaken bone structures, leading to an increased risk of developing osteoporosis and a greater propensity for serious bone fractures or breaks.
The potential for developing a condition known as osteonecrosis, a deadening of the jaw bone following an infection, is also believed to be higher among women who use Fosamax and other bone-density medications.
The US Drug Watchdog, a consumer advocacy group, has issued a nationwide call urging women who have used or are using Fosamax and similar drugs to contact their organization with details about their injuries. The group is particularly interested in those women who have used bone-density drugs within the last five years and experienced a serious fracture or break to their femur. According to a press release issued to the San Francisco Chronicle, the organization’s primary goal is to connect women who have suffered injuries after using Fosamax, Boniva or Actonel with a personal injury lawyer experienced in handling these types of claims.
Numerous lawsuits are still pending against Merck, which are scheduled to go to trial beginning in February 2012. The drug-maker has previously claimed victory in four of five bellweather trials which involved lawsuits claiming injuries stemming specifically from osteonecrosis allegations. At least one of the verdicts is likely to be appealed by the plaintiffs’ attorneys.
In September 2011, an advisory panel recommended new warning labels for Fosamax and similar drugs. These warnings are expected to come later this month, with the FDA advising Fosamax and other bone-density drug users of the potential for an increased risk of developing osteonecrosis and experiencing serious bone fractures. It is believed that the outcome of the next wave of product liability trials may determine whether the FDA decides to issue a full recall of Fosamax and its counterparts.
If you or a loved one has experienced a deterioration of the jawbone, broken bones or other serious injuries after using Fosamax or another bone-density drug, you need to contact a qualified California personal injury attorney today. The law firm of Nadrich & Cohen has investigated claims from women across the country regarding allegations of injuries caused by Fosamax side effects and we are dedicated to helping you get the compensation you’re entitled to.
Contact us at 1-800-722-0765 to find out how we can help. We offer a free initial case evaluation and we charge no fee unless we recover a money judgment on your behalf. Call us today to get expert legal representation for your Fosamax side effects injury lawsuit.